Skip to content
Home/Companies/Biotech/ABIONYX Pharma
AP

ABIONYX Pharma

Biotech·France·Exited 2020·Held 10yr

ABIONYX Pharma is a healthcare / biotech company, headquartered in France.

Entry
2010
Hold
10yr
Exit
2020
Est. EV
–

Who owns ABIONYX Pharma?

ABIONYX Pharma was owned by Sofinnova Partners through Sofinnova Capital VI (2008 vintage) from 2010 to 2020, exited via IPO.

Hand-verified · updated 2026-04-21

Sofinnova Partners
Investor
Sofinnova Partners
Sofinnova Capital VI · 2008 · Life Sciences VC

Key facts

HQFrance
SectorHealthcare / Biotech
Exit Type
IPO
Buyer
–
MOIC
–
Exit Year
2020

More from Sofinnova Capital VI

Other portfolio companies in the same fund.

DBV
Exited 2014
BiotechFrance· 2010
Omthera Pharmaceuticals
Exited 2013
BiotechUS· 2010
to
Ablynx NV
Exited 2018
BiotechBelgium· 2008
to
Addex Therapeutics
Exited 2012
BiotechSwitzerland· 2008
Movetis
Exited 2010
BiotechBelgium· 2008
to
Noxxon Pharma
Exited 2016
BiotechGermany· 2008

More PE-backed in Biotech

Comparable biotech deals from other GPs.

InBrain Pharma
Active
Finovam GestionFrance
Isavy Biotech
Active
Ring CapitalFrance
NeoVacs
Active
Odyssée VentureFrance
ReNeuron Group
Exited 2024
Obotritia CapitalUnited Kingdom
Univercells
Exited 2023
AdBio PartnersBelgium
to
2NA FISH
Active
Gruenderfonds RuhrGermany· 2026
Data refreshed weekly · Sourced from public filings